Health · Healthcare & Policy · 8 hrs ago

Cell transplants and other treatments offer hope for Type 1 diabetes

Cell transplants and other treatments offer hope for Type 1 diabetes

More than 830 million people worldwide are estimated to live with diabetes in 2026, and a 2023 analysis projects that number could exceed 1.3 billion by 2050.

More than 90% have Type 2 diabetes, while Type 1 happens when the immune system attacks cells that make insulin.

There is still no cure for Type 1 diabetes, but researchers are testing ways to replace those cells.

In clinical trials, most people given transplanted insulin-producing cells no longer needed insulin or needed much less, reducing their risk of dangerously low blood sugar.

The main obstacle is immune rejection, which can mean a lifetime of medicines that weaken the immune system.

Researchers are exploring ways to alter transplanted cells so they avoid attack, and targeted medicines that protect them without weakening the rest of the immune system.

Treatments that delay Type 1's progression are already available, while research into cell transplants and immune-targeting approaches continues.

1 source

Related

What people are saying

JamieHealthcare researcher who has lived with Type 1 diabetes for over 30 years
Some 30 years later, a cure that works for most people has yet to arrive.
via Independent
In clinical trials, the majority of people receiving transplanted insulin-producing cells either no longer needed insulin or could take significantly lower doses.
via Independent
The challenge, though, is the risk the body will recognize the new cells as foreign and launch an immune response against them.
via Independent